Ignite Creation Date:
2024-10-26 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06650852
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-10-12
Brief Title:
A Study to Evaluate the Efficacy and Safety of Combination Therapy of BRII-179 BRII-835 and PEG-IFNα in Participants With Chronic Hepatitis B Virus HBV Infection ENHANCE
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase 2 Multicenter Randomized Double-Blind Study to Evaluate the Efficacy and Safety of Combination Therapy of BRII-179 BRII-835 and Pegylated Interferon Alpha PEG-IFNα in Participants With Chronic Hepatitis B Virus HBV Infection ENHANCE
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This Phase 2 randomized double-blind study will evaluate the clinical efficacy and safety of the combination therapy of BRII-179 BRII-835 plus PEG-IFNα compared to PEG-IFNα in adult participants with chronic HBV infection without cirrhosis receiving neucloestide reverse transcriptase inhibitors NRTIs as background therapy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None